Decrease Implantation Site INFECTION : a Randomized Controlled Trial
NCT ID: NCT02217046
Last Updated: 2019-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
352 participants
INTERVENTIONAL
2013-12-31
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antimicrobial Strategy for Device Implantation
NCT07158502
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
NCT03346694
Taurolidine Containing Antimicrobial CIED Wash to Prevent Infection
NCT05576194
Safe-Infusion Study
NCT06727240
Randomized Study of Silq Urinary Catheter
NCT04841226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
But, studies of posterior pocket capsule removal is still limited.
The investigators had planned research on effects of posterior pocket capsule removal before cardiac devices replacement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
device replacement
remove previously inserted cardiac device and posterior pocket capsule. the pocket that will receive the heart mechanism is sterilized with a hydroperoxide soaked gauze
device replacement(pocket capsule removal)
remove previously inserted cardiac device and posterior pocket capsule. the pocket that will receive the heart mechanism is sterilized with a hydroperoxide soaked gauze
control group
remove previously inserted cardiac device and the pocket that will receive the heart mechanism is sterilized with a hydroperoxide soaked gauze
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
device replacement(pocket capsule removal)
remove previously inserted cardiac device and posterior pocket capsule. the pocket that will receive the heart mechanism is sterilized with a hydroperoxide soaked gauze
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* take an antibiotic
* history of infection within 30 days
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yong Seog Oh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yong Seog Oh
Ph.D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yong Seog Oh, Ph.D
Role: STUDY_CHAIR
Seoul St. Mary's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul St Mary's Hospital
Seoul, Seo Ch-gu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DISINFECTION II
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.